Atrion (NASDAQ:ATRI) versus Silk Road Medical (NASDAQ:SILK) Critical Survey

Atrion (NASDAQ:ATRIGet Rating) and Silk Road Medical (NASDAQ:SILKGet Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, institutional ownership, earnings, profitability and dividends.

Profitability

This table compares Atrion and Silk Road Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Atrion 19.56% 13.94% 12.58%
Silk Road Medical -51.93% -63.51% -34.14%

Analyst Recommendations

This is a summary of current recommendations and price targets for Atrion and Silk Road Medical, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Atrion 0 0 0 0 N/A
Silk Road Medical 0 2 3 0 2.60

Silk Road Medical has a consensus target price of $50.80, indicating a potential upside of 63.82%. Given Silk Road Medical’s higher probable upside, analysts plainly believe Silk Road Medical is more favorable than Atrion.

Insider & Institutional Ownership

77.4% of Atrion shares are owned by institutional investors. 22.7% of Atrion shares are owned by company insiders. Comparatively, 7.7% of Silk Road Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

Atrion has a beta of 0.18, indicating that its share price is 82% less volatile than the S&P 500. Comparatively, Silk Road Medical has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500.

Earnings and Valuation

This table compares Atrion and Silk Road Medical’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Atrion $165.01 million 6.68 $33.06 million $18.67 32.89
Silk Road Medical $101.47 million 10.66 -$49.81 million ($1.61) -19.26

Atrion has higher revenue and earnings than Silk Road Medical. Silk Road Medical is trading at a lower price-to-earnings ratio than Atrion, indicating that it is currently the more affordable of the two stocks.

Summary

Atrion beats Silk Road Medical on 9 of the 13 factors compared between the two stocks.

About Atrion (Get Rating)

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

About Silk Road Medical (Get Rating)

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.